Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04655157
Status:
TERMINATED
Last Update Posted:
2024-05-23
First Post:
2020-12-03
Brief Title:
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
Sponsor:
Jason J Luke MD
Organization:
University of Pittsburgh
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-03
First Submit QC Date:
December 3 2020
Study First Post Date:
2020-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-05-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-25
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL